Literature DB >> 15261930

Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials.

Pierfrancesco Agostoni1, Giuseppe G L Biondi-Zoccai, M Luisa de Benedictis, Stefano Rigattieri, Marco Turri, Maurizio Anselmi, Corrado Vassanelli, Piero Zardini, Yves Louvard, Martial Hamon.   

Abstract

OBJECTIVES: We sought to compare, through a meta-analytic process, the transradial and transfemoral approaches for coronary procedures in terms of clinical and procedural outcomes.
BACKGROUND: The radial approach has been increasingly used as an alternative to femoral access. Several trials have compared these two approaches, with inconclusive results.
METHODS: The MEDLINE, CENTRAL, and conference proceedings from major cardiologic associations were searched. Random-effect odds ratios (ORs) for failure of the procedure (crossover to different entry site or impossibility to perform the planned procedure), entry site complications (major hematoma, vascular surgery, or arteriovenous fistula), and major adverse cardiovascular events (MACE), defined as death, myocardial infarction, emergency revascularization, or stroke, were computed.
RESULTS: Twelve randomized trials (n = 3,224) were included in the analysis. The risk of MACE was similar for the radial versus femoral approach (OR 0.92, 95% confidence interval [CI] 0.57 to 1.48; p = 0.7). Instead, radial access was associated with a significantly lower rate of entry site complications (OR 0.20, 95% CI 0.09 to 0.42; p < 0.0001), even if at the price of a higher rate of procedural failure (OR 3.30, 95% CI 1.63 to 6.71; p < 0.001).
CONCLUSIONS: The radial approach for coronary procedures appears as a safe alternative to femoral access. Moreover, radial access virtually eliminates local vascular complications, thanks to a time-sparing hemostasis technique. However, gaining radial access requires higher technical skills, thus yielding an overall lower success rate. Nonetheless, a clear ongoing trend toward equalization of the two procedures, in terms of procedural success, is evident through the years, probably due to technologic progress of materials and increased operator experience.

Entities:  

Mesh:

Year:  2004        PMID: 15261930     DOI: 10.1016/j.jacc.2004.04.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  156 in total

1.  Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.

Authors:  Kent Feng; Vipul Gupta; Enrique Terrazas; Yerem Yeghiazarians; Thomas Ports; Gabriel Gregoratos; Mehdi Tavakol; John Paul Roberts; Andrew Boyle
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

2.  Critical hand ischaemia after transradial cardiac catheterisation: an uncommon complication of a common procedure.

Authors:  L M Rademakers; G J Laarman
Journal:  Neth Heart J       Date:  2012-09       Impact factor: 2.380

Review 3.  Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.

Authors:  Sandeep Nathan; Sunil V Rao
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

4.  Is Transradial Cerebral Angiography Feasible and Safe? A Single Center's Experience.

Authors:  Kwang Wook Jo; Sung Man Park; Sang Don Kim; Seong Rim Kim; Min Woo Baik; Young Woo Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

5.  Direct vasodilation by transdermal administration of nitroglycerin: preliminary, randomized, placebo-controlled trial of nitroglycerin skin spray for premedication before artery puncture.

Authors:  Keizo Tanitame; Chihiro Tani; Yuko Nakamura; Wataru Yamasaki; Masaki Ishikawa; Hideaki Kakizawa; Shuji Date; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2012-05       Impact factor: 2.374

6.  Radial versus femoral artery access for percutaneous coronary angiography and intervention: a systematic review and meta-analysis of randomized controlled trials in Chinese population.

Authors:  Peng Liu; Xue Liang Gao; Bei Fang Li; Xue Zhi Ding; Zi Hao Wang; Yan Ping Dang; Yang Gui Liu; Yun Fu Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Comparison of transradial and transfemoral artery approach for percutaneous coronary angiography and angioplasty: a retrospective seven-year experience from a north Indian center.

Authors:  Satyendra Tewari; Naveen Sharma; Aditya Kapoor; Sanjeev Kumar Syal; Sudeep Kumar; Naveen Garg; Pravin K Goel
Journal:  Indian Heart J       Date:  2013-07-12

8.  Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study.

Authors:  Luca Di Vito; Francesco Burzotta; Carlo Trani; Giancarlo Pirozzolo; Italo Porto; Giampaolo Niccoli; Antonio Maria Leone; Filippo Crea
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-24       Impact factor: 2.357

9.  TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.

Authors:  Connie N Hess; Sunil V Rao; David F Kong; Julie M Miller; Kevin J Anstrom; Olivier F Bertrand; Jean-Philippe Collet; Mark B Effron; Benjamin C Eloff; Emmanuel O Fadiran; Andrew Farb; Ian C Gilchrist; David R Holmes; Alice K Jacobs; Prashant Kaul; L Kristin Newby; David R Rutledge; Dale R Tavris; Thomas T Tsai; Roseann M White; Eric D Peterson; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2013-03       Impact factor: 4.749

10.  Radial versus femoral access site for percutaneous coronary intervention in patients suffering acute myocardial infarction : A randomized prospective multicenter trial.

Authors:  Christiana Schernthaner; Matthias Hammerer; Stefan Harb; Matthias Heigert; Kurt Hoellinger; Elisabeth Lassnig; Edwin Maurer; Jochen Schuler; Peter Siostrzonek; Hanno Ulmer; Andreas Winter; Johann Altenberger
Journal:  Wien Klin Wochenschr       Date:  2017-09-12       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.